186 related articles for article (PubMed ID: 22126847)
1. Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times.
Wahlin BE; Yri OE; Kimby E; Holte H; Delabie J; Smeland EB; Sundström C; Christensson B; Sander B
Br J Haematol; 2012 Jan; 156(2):225-33. PubMed ID: 22126847
[TBL] [Abstract][Full Text] [Related]
2. Follicular lymphoma grade 3: review and updates.
Vaidyanathan G; Czuczman MS
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):431-5. PubMed ID: 25066038
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.
Maeshima AM; Taniguchi H; Nomoto J; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Hum Pathol; 2013 Nov; 44(11):2529-35. PubMed ID: 23916290
[TBL] [Abstract][Full Text] [Related]
4. Natural history of follicular grade 3 non-Hodgkin's lymphoma.
Bierman PJ
Curr Opin Oncol; 2007 Sep; 19(5):433-7. PubMed ID: 17762566
[TBL] [Abstract][Full Text] [Related]
5. A clinicopathologic evaluation of follicular lymphoma grade 3A versus grade 3B reveals no survival differences.
Hsi ED; Mirza I; Lozanski G; Hill J; Pohlman B; Karafa MT; Coupland R
Arch Pathol Lab Med; 2004 Aug; 128(8):863-8. PubMed ID: 15270618
[TBL] [Abstract][Full Text] [Related]
6. The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma.
Pham RN; Gooley TA; Keeney GE; Press OW; Pagel JM; Greisman HA; Bensinger WI; Holmberg LA; Petersdorf SH; Maloney DG; Gopal AK
Bone Marrow Transplant; 2007 Dec; 40(11):1039-44. PubMed ID: 17922043
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum-soluble interleukin-2 receptor in patients with follicular lymphoma.
Yoshizato T; Nannya Y; Imai Y; Ichikawa M; Kurokawa M
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):410-6. PubMed ID: 23747081
[TBL] [Abstract][Full Text] [Related]
8. Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?
Chau I; Jones R; Cunningham D; Wotherspoon A; Maisey N; Norman AR; Jain P; Bishop L; Horwich A; Catovsky D
Br J Cancer; 2003 Jul; 89(1):36-42. PubMed ID: 12838297
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy.
Guadagnolo BA; Li S; Neuberg D; Ng A; Hua L; Silver B; Stevenson MA; Mauch P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):928-34. PubMed ID: 16243446
[TBL] [Abstract][Full Text] [Related]
10. Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy.
Shustik J; Quinn M; Connors JM; Gascoyne RD; Skinnider B; Sehn LH
Ann Oncol; 2011 May; 22(5):1164-1169. PubMed ID: 21062969
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of histologic grade and Ki-67 proliferation index in follicular lymphoma.
Xue T; Yu BH; Yan WH; Jiang XN; Tian T; Zhou XY; Li XQ
Hematol Oncol; 2020 Dec; 38(5):665-672. PubMed ID: 32627854
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.
Wahlin BE; Sander B; Christensson B; Kimby E
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):388-97. PubMed ID: 17255259
[TBL] [Abstract][Full Text] [Related]
13. Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL.
Koch K; Hoster E; Ziepert M; Unterhalt M; Ott G; Rosenwald A; Hansmann ML; Bernd W; Stein H; Pöschel V; Dreyling M; Trümper L; Löffler M; Schmitz N; Hiddemann W; Pfreundschuh M; Klapper W
Ann Oncol; 2016 Jul; 27(7):1323-9. PubMed ID: 27117536
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups.
Ozsan N; Bedke BJ; Law ME; Inwards DJ; Ketterling RP; Knudson RA; Keeney GL; Dogan A; Feldman AL
Am J Surg Pathol; 2011 Nov; 35(11):1691-9. PubMed ID: 21997689
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.
Rohatgi N; LaRocca RV; Bard V; Sethuraman G; Foon KA
Am J Hematol; 2002 Jul; 70(3):181-5. PubMed ID: 12111762
[TBL] [Abstract][Full Text] [Related]
17. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
Czuczman MS; Weaver R; Alkuzweny B; Berlfein J; Grillo-López AJ
J Clin Oncol; 2004 Dec; 22(23):4711-6. PubMed ID: 15483015
[TBL] [Abstract][Full Text] [Related]
18. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages.
Wahlin BE; Aggarwal M; Montes-Moreno S; Gonzalez LF; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
Clin Cancer Res; 2010 Jan; 16(2):637-50. PubMed ID: 20068089
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
20. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.
Federico M; Bellei M; Marcheselli L; Luminari S; Lopez-Guillermo A; Vitolo U; Pro B; Pileri S; Pulsoni A; Soubeyran P; Cortelazzo S; Martinelli G; Martelli M; Rigacci L; Arcaini L; Di Raimondo F; Merli F; Sabattini E; McLaughlin P; Solal-Céligny P
J Clin Oncol; 2009 Sep; 27(27):4555-62. PubMed ID: 19652063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
